Clinical Intelligence · Seizure Clarity in Dementia
Up to 40% of seizures in Alzheimer's produce no visible signs. They surface as blank stares, sudden mood shifts, and unexplained unresponsiveness — and they are being missed in nursing-home records, care portfolios, and clinical trials worldwide.
The Clinical Gap
A sudden mood shift. An episode of unresponsiveness that clears on its own. In a person with dementia, these are recorded as agitation, sundowning, natural decline — a behavioral note and a medication adjustment.
The peer-reviewed evidence establishes that the same signals are documented seizure presentations requiring neurological evaluation. That gap — between what is observed and what was knowable — is where Seagull Health works.
See how the DSS Framework classifies it →Seagull Health built all three — the clinical taxonomy, the intelligence engine that measures against it, and the briefs that put the finding where decisions are made.
The Name
The Dementia Seizure Spectrum classifies how seizures actually present in dementia across four domains — so a nurse can chart it, a family can say it, and an expert can defend it.
Dementia Seizure Spectrum™
The Measurement
CRISP searches and scores the published clinical literature against the framework, producing structured intelligence calibrated to the exact decision in front of you.
CRISP™ Intelligence Engine
The Consequence
The same finding, translated into the stake each decision-maker already holds — liability, valuation, trial design, clinical documentation.
Delivered briefs & SeizureSafe™ protocols
Every CRISP brief is commissioned for a specific question and delivered in the format the context demands — flat fee, 2–3 business days.
An evidentiary brief mapping behavioral signals in the clinical record to published seizure presentations in dementia — built for plaintiff-side nursing home negligence attorneys.
Litigation intelligence →Pre-acquisition and portfolio-level intelligence identifying seizure-related liability exposure in memory care and skilled nursing assets — for PE firms and REIT operators, before and after close.
Investment intelligence →Structured intelligence on the dementia-seizure overlap for trial design, endpoint development, and safety-signal interpretation — connecting the evidence base to your research question.
Life sciences intelligence →DSS Framework licensing and CRISP integration for monitoring and care platforms — the taxonomy that connects behavioral signals to structured neurological evidence.
Technology partnerships →Dementia Seizure Spectrum™
The clinical taxonomy — four domains describing how seizures present in dementia, person-level and setting-agnostic by design.
SeizureSafe™
The implementation layer — how care teams recognize, respond, document, and advocate once a risk is identified.
CRISP™
The engine — searching and scoring the published literature to produce the brief a specific decision requires.
The Dementia Seizure Spectrum™ is the clinical foundation. SeizureSafe™ is how you use it. CRISP™ is how we know.
A seizure no one was trained to see is not behavior. It is a missed diagnosis — in every country where people grow old. Read what we stand for.